Table 1.
Evidence for Cellular Origins of Metaplasia
| Evidence for chief cells | Evidence for Mist1+ isthmus stem cells | |
|---|---|---|
| Proliferation | None in normal state, and minimal (<5%) in injury | Normally slow proliferation, and marked expansion in injury |
| BrdU labeling | No uptake in normal state, with rare labeling after injury (eg, 5-FU), but no upward migration8 | Labeled cells migrate bidirectionally from the isthmus upward toward the pits and downward to the base |
| Lineage tracing |
Troy-derived long-term tracing in haploinsufficient Troy knockin models,8 but not in Troy BAC models6 Chief cells express Lgr5, but no tracing from Lgr5+ chief cells in normal and injury states9; ablation of Lgr5+ chief cells does not decrease Mist1-derived tracing6 No evidence that chief cells expand clonally |
Mist1-CreERT labels the isthmus stem cell as well as chief cells, and tracing arises from the isthmus stem cell6 5-FU–induced stem cell ablation eliminates Mist1 tracing6 Confetti mice show clonal expansion from the isthmus6 eR1-CreERT mice show lineage tracing from the isthmus10 |
| DMP-777 | TFF2+IF+ cells present in lower third of glands after treatment, but morphology of these SPEM cells is atypical and changes are transient (<2 wk) DMP-777 reduces Mist1-traced chief cell number5, 6 |
Mist1+ isthmus stem cell–derived tracing is not altered after DMP-7776 Human gastric metaplasia is stable and clonal with a field effect, indicating stem cell origins3 |
| Mutant Kras | Proliferating GS2+IF+ cells at the base after 1 month7 eR1-CreERT with Kras mutation leads to occasional GS2+ metaplasia near the gland base10 Most chief cells do not proliferate even after Kras induction at early time points, and are replaced rapidly by the migration of isthmus-derived SPEM cluster |
Mucous-producing proliferating GS2/MUC6+ SPEM that is Alcian blue+ is present early on only in the isthmus Gland fission is present early only in the isthmus Lgr5-DTR–mediated ablation of chief cells does not reduce metaplasia, whereas suppression of the isthmus stem cell (with 5-FU) blocks metaplasia6 Metaplasia in eR1-CreERT;LSL-Kras mice starts primarily in the isthmus10 |
BrdU, bromodeoxyuridine; 5-FU, 5-fluorouracil.